# DARIFENACIN

NDC: 62332-224
Generic name: DARIFENACIN
Labeler / Manufacturer: Alembic Pharmaceuticals Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET, EXTENDED RELEASE
Routes: ORAL
Marketing started: 20171212

FDA application: ANDA207681

## Active ingredients

- DARIFENACIN HYDROBROMIDE: 15 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"62332-224"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=62332-224
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=9f6952c8-e547-4f3e-a978-a88d6ea9dc10